Looking over the results and reading through the earnings call transcript we can’t decide which fairy tale is MannKind (NASDAQ: MNKD) telling. Is MannKind the little engine that could or is it Humpty Dumpty? In many respects the MannKind tale is the tale of how our wacky world works. This is a company which at one time was the darling of the street full of promise and hope. Only to see these hopes crushed which pushed the company to verge of bankruptcy.
The reality is MannKind has never been a drug story as Afrezza does work and there is . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.